Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative). (Q39019484)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 January 2017

Language	Label	Description	Also known as
English	Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).	scientific article published on 12 January 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative). (English)

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

systemic therapy

1 reference

based on heuristic

inferred from title

Constance T Cirrincione

2

object named as

Constance T Cirrincione

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

7

object named as

Eric P Winer

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

8

object named as

Mehra Golshan

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5616181

PMC publication ID

Clifford A Hudis

6

object named as

Clifford A Hudis

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5616181

PMC publication ID

author name string

David W Ollila

1

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

Donald A Berry

3

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

Lisa A Carey

4

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

William M Sikov

5

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

publication date

13 January 2017

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

Journal of the American College of Surgeons

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

224

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

4

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

688-694

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

15 July 2018

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

15 July 2018

Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

15 July 2018

Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

15 July 2018

Noninvasive nodal restaging in clinically node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

15 July 2018

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

15 July 2018

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

15 July 2018

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

15 July 2018

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

15 July 2018

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

15 July 2018

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

15 July 2018

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

15 July 2018

Primary Systemic Treatment in the Management of Operable Breast Cancer: Best Surgical Approach for Diagnosis, Biological Evaluation, and Research.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

21 August 2018

Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

21 August 2018

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

21 August 2018

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5616181

21 August 2018

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/28089784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28089784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/28089784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/28089784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://pubmed.ncbi.nlm.nih.gov/28089784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JAMCOLLSURG.2016.12.036

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 July 2018

http://europepmc.org/abstract/PMC/5616181

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39019484&oldid=2117156309"